Equity Transactions (Tables)

6 Months Ended

Dec. 31, 2020

Schedule of proceeds of the offering

The Company accounted for the proceeds of the Offering at July 10 2020 as follows:

Gross proceeds	$	11,499,997
Less: offering costs and expenses		(1,057,781)
Net proceeds from issuance of common stock	$	10,442,216

Schedule of estimation of estimated the fair value of the warrants granted

The Company estimated the fair value of the warrants granted to the Scientific Advisory Board on the date of grant using the Black-Scholes Option-Pricing Model with the following weighted-average assumptions:

Expected life (year)	4
Expected volatility	91.4-91.5	%
Expected annual rate of quarterly dividends	0.00	%
Risk-free rate(s)	.24-.32	%

Series A Preferred stock

Schedule of fair value of Series A Preferred Stock

The fair value of the Series A Preferred stock was the following for the dates indicated:

Date	Shares	Value
7/31/2020	129	$	3,155
8/31/2020	129		2,391
9/30/2020	129		1,898
10/31/2020	129		1,749
11/30/2020	129		1,596
12/31/2020	129		1,603
	774	$	12,392